Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells von Krug, Sebastian, Mordhorst, Jan-Philipp, Moser, Fabian, Theuerkorn, Katharina, Ruffert, Claudia, Egidi, Maren, Rinke, Anja, Gress, Thomas M, Michl, Patrick

Volltext

Correction: Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells von Krug, Sebastian, Mordhorst, Jan-Philipp, Moser, Fabian, Theuerkorn, Katharina, Ruffert, Claudia, Egidi, Maren, Rinke, Anja, Gress, Thomas M, Michl, Patrick

Volltext

Anti-angiogenic therapy using the multi-tyrosine kinase inhibitor Regorafenib enhances tumor progression in a transgenic mouse model of ß-cell carcinogenesis von Egidi, Maren Juliane, Krug, Sebastian, Haybaeck, Johannes, Michl, Patrick, Griesmann, Heidi

Volltext

Non-tumour cell autonomous effects of antiangiogenic multikinase inhibitor regorafenib on infiltrating macrophages in pancreatic neuroendocrine tumours von Egidi, Maren, Griesmann, Heidi, Michl, Patrick, Krug, Sebastian

Volltext

Impact of pharmacological macrophage depletion on the progression of pancreatic neuroendocrine neoplasms von Krug, Sebastian, Abassi, Rami, Griesmann, Heidi, Egidi, Maren, Rinke, Anja, Gress, Thomas, Michl, Patrick

Volltext

miRNA-21 modulates tumour progression by altering the functional phenotype of tumour-associated macrophages in pancreatic cancer von Muehlberg, Leonie, Kuehnemuth, Benjamin, Costello, Eithne, Shaw, Victoria, Griesmann, Heidi, Egidi, Maren, Schober, Marvin, Gress, Thomas, Michl, Patrick

Volltext